← Leaderboards
Terry Hubbard
3dt Holdings, Llc
$1,720,595
Attributed
$4,738,192
Total exposure
5
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2.6M · FY2018–24$5M$3.8M$2.5M$1.3M$0
'18
'19
'20
'21
'22
'23
'24
Funding mix
By agency
NIH$4,738,192 · 5
By mechanism
R44$3,565,474 · 2
R43$1,172,718 · 3
Top collaborators
- Ghassan S Kassab6 shared
- Mengjun Wang3 shared
- Xiao Lu1 shared
Most similar at 3dt Holdings, Llc
Same institution · by research overlap
- Ghassan S Kassab$29,569,425
- Mengjun Wang$2,210,382
- Xiao Lu$248,206
- Kyle Bates$142,704
- Gregory S Kelley$857,314
Others in their field
Other Emerging Leaders on “Cost”
- Valerie Koch · University Corporation For Atmospheric Res$243,972,016
- Scott Topper · Broad Institute, Inc.$77,958,806
- Yunda Huang · Fred Hutchinson Cancer Center$51,342,169
- Mark Marino · Venturewell$48,913,644
- John Damon Chodera · Sloan-Kettering Inst Can Research$48,367,817
- Leonard Freedman · Leidos Biomedical Research, Inc.$41,527,040
Research focus
CostFamily SuidaePressureHealth Care CostsUnited States National Institutes Of HealthOperative Surgical ProceduresSafetyInstitutesVenousPatient PopulationTechnologyDevicesChronicLungAnteriorIschemiaAnimalsIn VivoLifeBiocompatible MaterialsHistologicAwardHealthcareImplantation
Grant awards (6)
Novel Tracheostoma Device$400,000
R43 · FY2024 · CA · contact PI
Device for Treatment of Cardiac No-Option Patients$991,925
R44 · FY2019 · HL
Novel Leaflet Biomaterial for Pulmonary Artery Valve$447,184
R43 · FY2019 · HL · contact PI
Small Peripheral Vessel Graft$325,534
R43 · FY2019 · HL · contact PI
Device for Treatment of Cardiac No-Option Patients$1,432,551
R44 · FY2018 · HL
Mild Hypothermia Catheter for Reperfusion Injury$1,140,998
R44 · FY2018 · HL · contact PI